Nov 10, 2025 04:15PM
Nov 6, 2025 11:00AM
Nov 6, 2025 11:00AM
Aug 12, 2025 05:52PM
Aug 12, 2025 04:01PM
Jul 15, 2025 07:30AM
Jul 15, 2025 07:30AM ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel
Jul 8, 2025 07:00AM
Jul 8, 2025 07:00AM
May 12, 2025 05:08PM
May 12, 2025 04:15PM
Mar 17, 2025 07:30AM
Nov 12, 2024 07:36AM
Nov 12, 2024 07:30AM ProKidney Reports Third Quarter 2024 Financial Results along with Regulatory and Clinical Development Updates Following Successful FDA Type B Meeting
Sep 3, 2024 07:31AM
Sep 3, 2024 07:30AM
Aug 13, 2024 04:59AM
Aug 9, 2024 07:00AM
May 21, 2024 07:00AM
May 10, 2024 07:00AM
Mar 25, 2024 06:06AM ProKidney Corp (PROK) Announces Leadership Changes
Mar 25, 2024 06:05AM
Mar 21, 2024 07:49PM
Nov 30, 2023 06:05AM
Nov 21, 2023 06:05AM
Nov 14, 2023 06:41AM
Nov 14, 2023 06:05AM
Nov 13, 2023 05:02PM ProKidney (PROK) Reports Positive Interim Data from RMCL-002 Phase 2 Clinical Trial of Renal Autologous Cell Therapy
Nov 13, 2023 05:02PM
Oct 30, 2023 04:12PM
Sep 5, 2023 06:05AM
Aug 10, 2023 04:14PM
Aug 10, 2023 04:10PM
Jul 18, 2023 06:05AM
Jul 17, 2023 06:05AM ProKidney Appoints Bruce Culleton, MD, as Executive Vice President, Clinical Development and Commercialization
Jun 13, 2023 12:05PM
Jun 1, 2023 04:05PM
May 11, 2023 04:01PM
May 4, 2023 06:05AM
Mar 28, 2023 04:12PM
Mar 28, 2023 04:12PM
Mar 3, 2023 06:05AM ProKidney to Participate in TD Cowen’s 43rd Annual Health Care Conference
Jan 10, 2023 04:06PM
Jan 10, 2023 04:05PM
Dec 22, 2022 06:05AM
Nov 14, 2022 06:05AM
Nov 11, 2022 04:05PM
Nov 3, 2022 06:08AM
Nov 3, 2022 06:05AM ProKidney Receives Allowance from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) for proact 1 (REGEN-006) and EMA Scientific Advice on Phase 3 Protocols of REACT for Diabetic Chroni
Oct 14, 2022 12:00PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All